The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Big Pharma Split's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.17.
The historical rank and industry rank for Big Pharma Split's Dividend Payout Ratio or its related term are showing as below:
TSX:PRM'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.35 Med: 0.57 Max: 0.78
Current: 0.37
During the past 9 years, the highest Dividend Payout Ratio of Big Pharma Split was 0.78. The lowest was 0.35. And the median was 0.57.
TSX:PRM's Dividend Payout Ratio is not ranked
in the Asset Management industry.
Industry Median: 0.71
vs TSX:PRM: 0.37
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of Big Pharma Split was 10.10% per year. The lowest was 0.00% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Big Pharma Split (TSX:PRM) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Big Pharma Split Dividend Payout Ratio Related Terms
Big Pharma Split Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Big Pharma Split's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSX:PRM vs BLK, BX, KKR: Dividend Payout Ratio Comparison
For the Asset Management subindustry, Big Pharma Split's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Big Pharma Split Dividend Payout Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Big Pharma Split's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Big Pharma Split's Dividend Payout Ratio falls into.
Big Pharma Split Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Big Pharma Split's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Big Pharma Split (TSX:PRM) has a Dividend Payout Ratio of 0.17 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Big Pharma Split and its competitors. This is 70% below median its historical median of 0.57. Over the past decade, Big Pharma Split's Dividend Payout Ratio has ranged from 0.35 to 0.78.
Is Big Pharma Split's Dividend Payout Ratio too high?
Big Pharma Split's current Dividend Payout Ratio of 0.17 is 70% below median its 10-year median of 0.57. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 0.78. The Asset Management industry median Dividend Payout Ratio is 0.71. Big Pharma Split's value of 0.17 is 76.1% below this industry median. Overall, Big Pharma Split has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Big Pharma Split's Dividend Payout Ratio compare to BLK and BX?
Big Pharma Split's Dividend Payout Ratio of 0.17 can be compared against companies in the Asset Management industry. The industry median Dividend Payout Ratio is 0.71. Big Pharma Split's value of 0.17 is 76.1% below this benchmark. Historically, Big Pharma Split's own Dividend Payout Ratio has ranged from 0.35 to 0.78 over the past decade. While the company's 10-year median is 0.57 vs. the industry median of 0.71, Big Pharma Split has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for an Asset Management company?
The median Dividend Payout Ratio among Asset Management companies is 0.71, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Big Pharma Split's current Dividend Payout Ratio of 0.17 is 76.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Big Pharma Split and its competitors. For the Asset Management industry, the median Dividend Payout Ratio is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Big Pharma Split's current Dividend Payout Ratio is 0.17, which is 70% below median its own 10-year median of 0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Big Pharma Split stock overvalued right now?
Big Pharma Split (TSX:PRM) has a current Dividend Payout Ratio of 0.17. The stock's GF Value™ is C$1.80, compared to a current price of C$11.61 — trading 545% above its estimated fair value. The current Dividend Payout Ratio is 0.17, which is 70% below median its 10-year median of 0.57 and 76.1% below the Asset Management industry median of 0.71. Big Pharma Split's overall GF Score™ is 7/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Big Pharma Split (TSX:PRM), the current Dividend Payout Ratio is 0.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Big Pharma Split (TSX:PRM) Overvalued in 2026?
Based on GuruFocus' analysis, Big Pharma Split stock appears to be overvalued.
The current stock price of C$11.61 is trading 545% above its estimated GF Value™ of C$1.80.
Key valuation signals for TSX:PRM:
Dividend Payout Ratio: 0.17 (70% below median its 10-year median of 0.57)
GF Value™: C$1.80 vs. price of C$11.61 (545% above fair value)
Industry Position: 76.1% below the Asset Management median
No single metric tells the full story. See the TSX:PRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Big Pharma Split Corp is a closed end mutual fund corporation. The investment objective of the company is to provide shareholders with fixed cumulative preferential quarterly cash distributions and regular monthly cash distributions. The company has a presence in the United States, France, and the United Kingdom.
7GF Score
Get the complete analysis for TSX:PRM
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:PRM has been successfully added to your 
